During the past decade, Baylor Regional Transplant Institute - Baylor University Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor Regional Transplant Institute - Baylor University Medical Center" #1 sponsor was "Baylor Research Institute" with 2 trials, followed by "Y's Therapeutics, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Conatus Pharmaceuticals Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor Regional Transplant Institute - Baylor University Medical Center" #1 collaborator was "Baylor Health Care System" with 2 trials as a collaborator, "Emory University" with 1 trials as a collaborator, "Idun Pharmaceuticals" with 1 trials as a collaborator, "Lahey Clinic" with 1 trials as a collaborator and "Mayo Clinic - Rochester, Minnesota" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Baylor Regional Transplant Institute - Baylor University Medical Center" are "Carcinoma, Hepatocellular" (1 trials), "Cholestasis" (1 trials), "Delayed Graft Function" (1 trials), "End Stage Liver Disease" (1 trials) and "Hepatitis" (1 trials). Many other conditions were trialed in "Baylor Regional Transplant Institute - Baylor University Medical Center" in a lesser frequency.

Most popular intervention types in "Baylor Regional Transplant Institute - Baylor University Medical Center" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tacrolimus" (2 trials), "YSPSL" (2 trials), "CP-690,550" (1 trials), "Cyclosporine" (1 trials) and "Daclizumub" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Regional Transplant Institute - Baylor University Medical Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Regional Transplant Institute - Baylor University Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Baylor Regional Transplant Institute - Baylor University Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Regional Transplant Institute - Baylor University Medical Center, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".